DK1053239T3 - Gluccocorticoid-selektive, anti-inflammatoriske midler - Google Patents

Gluccocorticoid-selektive, anti-inflammatoriske midler

Info

Publication number
DK1053239T3
DK1053239T3 DK99906996T DK99906996T DK1053239T3 DK 1053239 T3 DK1053239 T3 DK 1053239T3 DK 99906996 T DK99906996 T DK 99906996T DK 99906996 T DK99906996 T DK 99906996T DK 1053239 T3 DK1053239 T3 DK 1053239T3
Authority
DK
Denmark
Prior art keywords
gluccocorticoid
selective
inflammatory agents
mammal
compounds
Prior art date
Application number
DK99906996T
Other languages
Danish (da)
English (en)
Inventor
Michael J Coughlan
Michael E Kort
Philip R Kym
Jimmie L Moore
John K Pratt
Alan X Wang
James P Edwards
Todd K Jones
Steven W Elmore
Original Assignee
Abbott Lab
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Ligand Pharm Inc filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1053239T3 publication Critical patent/DK1053239T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK99906996T 1998-02-13 1999-02-12 Gluccocorticoid-selektive, anti-inflammatoriske midler DK1053239T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2394798A 1998-02-13 1998-02-13
US24783199A 1999-02-10 1999-02-10
PCT/US1999/003127 WO1999041256A1 (en) 1998-02-13 1999-02-12 Glucocorticoid-selective anti-inflammatory agents

Publications (1)

Publication Number Publication Date
DK1053239T3 true DK1053239T3 (da) 2003-04-22

Family

ID=26697833

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99906996T DK1053239T3 (da) 1998-02-13 1999-02-12 Gluccocorticoid-selektive, anti-inflammatoriske midler

Country Status (21)

Country Link
EP (1) EP1053239B1 (xx)
JP (1) JP2002503665A (xx)
KR (1) KR20010040935A (xx)
CN (1) CN1119348C (xx)
AT (1) ATE230749T1 (xx)
AU (1) AU766441B2 (xx)
BG (1) BG64317B1 (xx)
BR (1) BR9907788A (xx)
CA (1) CA2320943A1 (xx)
DE (1) DE69904804T2 (xx)
DK (1) DK1053239T3 (xx)
ES (1) ES2192035T3 (xx)
HK (1) HK1033308A1 (xx)
HU (1) HUP0100460A3 (xx)
IL (1) IL137508A0 (xx)
NO (1) NO20004053L (xx)
NZ (1) NZ506013A (xx)
PL (1) PL193323B1 (xx)
SK (1) SK284689B6 (xx)
TR (1) TR200003094T2 (xx)
WO (1) WO1999041256A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506766B1 (en) 1998-02-13 2003-01-14 Abbott Laboratories Glucocortiocoid-selective antinflammatory agents
US6593480B2 (en) * 1999-09-01 2003-07-15 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
US6329534B1 (en) 1999-09-01 2001-12-11 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
CO5180649A1 (es) * 1999-09-01 2002-07-30 Abbott Lab Antagonistas de los receptores de los glucocorticoides para el tratamiento de la diabetes para el tratamiento de la diabetes
US6436986B1 (en) 1999-09-01 2002-08-20 Abbott Laboratories Glucocorticoid receptor antagonists for treatment of diabetes
ATE303369T1 (de) 2000-10-30 2005-09-15 Pfizer Prod Inc Glucocorticoid rezeptor modulatoren
US6608216B2 (en) 2001-06-29 2003-08-19 Abbott Laboratories Process for the preparation of chiral glucocorticoid receptor agents
WO2003002548A1 (en) * 2001-06-29 2003-01-09 Abbott Laboratories A process for the preparation of chiral glucocorticoid receptor agents
US6518430B1 (en) 2001-09-21 2003-02-11 Abbott Laboratories Process for the preparation of 5-(substituted)-10-methoxy-2,2,4-trimethyl-2,5-dihydro-1H-chromeno[3,4-F]quinolines and derivatives thereof
CA2472746A1 (en) 2002-01-14 2003-07-24 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
EP1490317A1 (en) 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
ES2298508T3 (es) 2002-03-26 2008-05-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para prepararlos, composiciones farmaceuticas y sus usos.
AU2003221706B2 (en) 2002-04-11 2008-02-28 Merck Sharp & Dohme Corp. 1H-Benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
US7186864B2 (en) 2002-05-29 2007-03-06 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
CA2496175A1 (en) 2002-08-21 2004-03-04 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
DE20301728U1 (de) 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
WO2004033459A1 (en) * 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-CYCLOALKYL/ALKENYL)METHYLIDENE 1,2-DIHYDRO-5H-CHROMENO[3,4-f]QUINOLINES AS SELECTIVE PROGESTERONE RECEPTOR MODULATOR COMPOUNDS
AR040782A1 (es) * 2002-10-11 2005-04-20 Ligand Pharm Inc Derivados de 5- cicloalquenil-5h- cromeno [ 3,4- f] quinolina como compuestos mudulares selectivos de receptores de progesterona
CA2512257A1 (en) 2003-01-03 2004-07-29 Boehringer Ingelheim Pharmaceuticals, Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
US20070088042A1 (en) 2004-09-09 2007-04-19 Meissner Robert S Fluorinated 4-azasteroid derivatives as androgen receptor modulators
US7235662B2 (en) 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8097606B2 (en) 2003-07-23 2012-01-17 Corcept Therapeutics, Inc. Antiglucocorticoids for the treatment of catatonia
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
JP4468369B2 (ja) 2003-10-16 2010-05-26 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド ある種のトリフルオロメチル置換アルコールの立体選択的合成
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
EP1836166B1 (en) 2004-12-27 2009-06-17 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
PL1944290T3 (pl) * 2005-09-14 2014-07-31 Ayumi Pharmaceutical Corp Nowa pochodna 1-2-dihydrochinoliny mająca aktywność wiązania glukokortykoidowego receptora
AR077101A1 (es) 2009-06-16 2011-08-03 Schering Corp Esteroides de heteroarilo (3,2-c), como agonistas de receptor glucocorticoide, composiciones y usos de los mismos
EP2459524A2 (en) 2009-07-31 2012-06-06 Cadila Healthcare Limited Novel compounds as modulators of glucocorticoid receptors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69533180T2 (de) * 1994-12-22 2005-07-14 Ligand Pharmaceuticals, Inc., San Diego Steroidrezeptor-Modulator Verbindungen und Methoden

Also Published As

Publication number Publication date
HK1033308A1 (en) 2001-08-24
JP2002503665A (ja) 2002-02-05
NO20004053D0 (no) 2000-08-11
AU766441B2 (en) 2003-10-16
ES2192035T3 (es) 2003-09-16
WO1999041256A1 (en) 1999-08-19
PL343018A1 (en) 2001-07-30
NZ506013A (en) 2003-03-28
CN1296486A (zh) 2001-05-23
CN1119348C (zh) 2003-08-27
BG104719A (en) 2001-05-31
IL137508A0 (en) 2001-07-24
AU2677399A (en) 1999-08-30
PL193323B1 (pl) 2007-02-28
KR20010040935A (ko) 2001-05-15
HUP0100460A2 (hu) 2001-09-28
EP1053239A1 (en) 2000-11-22
TR200003094T2 (tr) 2001-01-22
SK11972000A3 (sk) 2001-08-06
SK284689B6 (sk) 2005-09-08
DE69904804T2 (de) 2003-11-06
EP1053239B1 (en) 2003-01-08
HUP0100460A3 (en) 2003-03-28
CA2320943A1 (en) 1999-09-19
BG64317B1 (bg) 2004-09-30
NO20004053L (no) 2000-09-11
DE69904804D1 (de) 2003-02-13
ATE230749T1 (de) 2003-01-15
BR9907788A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
DK1053239T3 (da) Gluccocorticoid-selektive, anti-inflammatoriske midler
DK1053240T3 (da) Glucocorticoid-selektiv antiinflammatoriske midler
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
TR200100189T2 (tr) Hücre yapışması engelleyici iltihaplanmaya karşı bileşikler
BG105653A (en) Aromatic heterocyclic compounds as anti-inflammatory agents
BG105880A (en) Compounds useful as anti-inflammatory agents
BR9811099A (pt) Inibidores de urocinase
ATE296283T1 (de) Zelladhäsion- und entzündungshemmende immunosuppressive verbindungen
AU1617901A (en) Urea derivatives as anti-inflammatory agents
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
WO2000006137A3 (en) Glucocorticoid-selective anti-inflammatory agents
MY128261A (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
IT1274022B (it) Derivati della cumarina ad attivita' farmacologica, loro uso e composizioni farmaceutiche che li contengono